TyraTech acquired by American Vanguard Corp.

TyraTech, Inc. (AIM: TYR), a publicly-traded AIM market life sciences company focused on nature-derived insect and parasite control products, merged with American Vanguard Corp. (NYSE: AVD). Prior to the transaction, American Vanguard held approximately 35% of the shares of Tyratech. The transaction included de-listing of Tyratech shares from the AIM market.

Waller served as lead counsel to TyraTech in the transaction.

For additional information, see media coverage here.

Related Experience

Heritage Group sells Abode Healthcare to Tailwind Capital

Represented Heritage Group in its sale of Abode Healthcare, an independent hospice and home health provider, to Tailwind Capital.

Accel-KKR invests in Sandata Technologies

Served as special healthcare regulatory counsel to Accel-KKR in its investment in Sandata Technologies, the leading provider of Electronic Visit Verification and home health technology solutions.

Mid-Atlantic Dental Partners acquires DentalOne Partners

Represented Mid-Atlantic Dental Partners in the transaction and assisted with regulatory compliance and corporate matters.

View More